Global Medical Stents Market Size By Type (Peripheral, Coronary), By Application (Surgical, Medical Intervention), By Region, And Segment Forecasts, 2023 to 2032

The Global Medical Stents Market was valued at USD 10.7 billion in 2023 and is projected to reach USD 18.9 billion by 2031, growing at a CAGR of 7.3% during the forecast period of 2023 to 2031. This market is witnessing substantial growth driven by the increasing prevalence of cardiovascular diseases, advancements in stent technologies, and the rising geriatric population. Medical stents are critical devices used to prevent artery blockages, ensuring uninterrupted blood flow, and have become a cornerstone in the management of coronary and peripheral artery diseases.

Drivers:

1. Rising Incidence of Cardiovascular Disorders:

The global burden of cardiovascular conditions such as coronary artery disease and peripheral vascular disease continues to rise, necessitating effective treatment options like stents to restore normal blood flow and prevent further complications.

2. Technological Advancements in Stent Design:

Innovations such as bioresorbable stents, drug-eluting stents (DES), and customized stent delivery systems are enhancing patient outcomes, minimizing restenosis, and driving adoption among healthcare professionals.

3. Increasing Geriatric Population:

With age being a major risk factor for arterial diseases, the growing aging population significantly contributes to the demand for medical stents worldwide.

Restraints:

1. High Cost of Advanced Stents:

The high cost associated with premium stents, such as drug-eluting or bioresorbable stents, can limit accessibility in developing economies, especially in public healthcare settings.

2. Risk of Post-Procedure Complications:

Complications like stent thrombosis, restenosis, or allergic reactions to the stent material continue to be significant concerns that may affect patient acceptance and physician recommendations.

Opportunity:

1. Emerging Markets and Healthcare Infrastructure Expansion:

Rapid urbanization, economic development, and government initiatives to strengthen healthcare infrastructure in regions like Asia-Pacific and Latin America offer lucrative growth opportunities for stent manufacturers.

2. Integration with Digital Health Technologies:

The incorporation of stent monitoring technologies and AI-powered imaging tools in cardiovascular procedures opens up new possibilities for improving post-operative care and procedural success rates.

Market by System Type Insights:

Among system types, Drug-Eluting Stents (DES) dominated the market in 2023 due to their proven efficacy in reducing restenosis and their widespread clinical adoption. DES is expected to maintain its lead through 2031 as newer generations with enhanced polymer coatings and drug formulations enter the market. Meanwhile, Bioresorbable Stents are projected to experience the fastest growth, driven by their promise of temporary scaffolding with minimal long-term complications.

Market by End-use Insights:

In 2023, Hospitals were the largest end-use segment, accounting for more than 60% of the market revenue, owing to the high volume of stenting procedures conducted in hospital settings. Cardiac centers are anticipated to show notable growth over the forecast period due to their increasing specialization in interventional cardiology and availability of advanced infrastructure.

Market by Regional Insights:

North America led the market in 2023, driven by high healthcare expenditure, strong presence of key players, and advanced diagnostic capabilities. Asia-Pacific is forecasted to register the highest CAGR from 2023 to 2031, fueled by rising patient awareness, increasing healthcare access, and a growing burden of chronic diseases in countries like China and India.

Competitive Scenario:

Key players in the Global Medical Stents Market include Boston Scientific Corporation, Medtronic plc, Abbott Laboratories, Terumo Corporation, B. Braun Melsungen AG, MicroPort Scientific Corporation, BIOTRONIK SE & Co. KG, and Cook Medical Inc. These companies are focusing on technological advancements, strategic collaborations, and global expansion to strengthen their market footprint.

Scope of Work – Global Medical Stents Market

Report Metric Details

Market Size (2023) USD 10.7 billion

Projected Market Size (2031) USD 18.9 billion

CAGR (2023–2031) 7.3%

Market Segments System Type (Bare Metal Stents, Drug-Eluting Stents, Bioresorbable Stents), End-use (Hospitals, Ambulatory Surgical Centers, Cardiac Centers)

Growth Drivers Increasing cardiovascular diseases, technological innovation, aging population

Opportunities Expanding healthcare in emerging markets, AI-integrated diagnostics

Key Market Developments:

March 2024: Abbott launched a next-generation drug-eluting stent with enhanced polymer coating for improved endothelial healing.

July 2023: Boston Scientific received FDA approval for its new bioresorbable stent, marking a significant shift toward temporary implantable solutions.

September 2023: Medtronic collaborated with a leading Asian healthcare provider to supply drug-eluting stents across major cardiac centers in India.

FAQs:

1) What is the current market size of the Global Medical Stents Market?

The market was valued at USD 10.7 billion in 2023.

2) What is the major growth driver of the Global Medical Stents Market?

The primary growth driver is the rising incidence of cardiovascular diseases worldwide.

3) Which is the largest region during the forecast period in the Global Medical Stents Market?

North America is currently the largest market, while Asia-Pacific is expected to grow the fastest.

4) Which segment accounted for the largest market share in Global Medical Stents Market?

The Drug-Eluting Stents (DES) segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Medical Stents Market?

Key players include Boston Scientific, Abbott Laboratories, Medtronic, Terumo, B. Braun, MicroPort, BIOTRONIK, and Cook Medical.